Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Drug and Device Product Liability Litigation Strategy

by Mark Herrmann , David B. Alden
Save 17% Save 17%
Current price ₹29,928.00
Original price ₹35,914.00
Original price ₹35,914.00
Original price ₹35,914.00
(-17%)
₹29,928.00
Current price ₹29,928.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Book cover type: Paperback
  • ISBN13: 9780199734948
  • Binding: Paperback
  • Subject: N/A
  • Publisher: Oxford University Press, USA
  • Publisher Imprint: Oxford University Press, USA
  • Publication Date:
  • Pages: 544
  • Original Price: GBP 210.0
  • Language: English
  • Edition: 1
  • Item Weight: 794 grams
  • BISAC Subject(s): Litigation

Each year, thousands of lawsuits are filed in federal and state courts seeking recovery from manufacturers of pharmaceuticals and medical devices. These lawsuits include individual actions, actions consolidated into multidistrict litigation, and class actions. The litigation occasionally becomes life-threatening for the defendant corporations, and may breed a public relations nightmare, as occurred with Vioxx, breast implants, and fen-phen.

Drug and Device Product Liability Litigation Strategy, by Mark Herrmann and David B. Alden, offers assistance to lawyers who practice in this high-stakes, high-profile, and rapidly-evolving area. The book's primary focus is to provide useful practice pointers and overall strategic guidance for attorneys in product liability litigation involving prescription drugs and medical devices. It will serve as an indispensable guide to handling such a case from pre-litigation through trial. The legal landscape in this important area is expected to shift as the Supreme Court's decisions in Riegel v. Medtronic, Inc. and Wyeth v. Levine are applied, and as the President and Congress address tort reform and other health care issues. Practitioners will need thoughtful, expert advice to navigate these changes.

Mark Herrmann is Vice President and Chief Counsel - Litigation at Aon Corporation, which is the world's leading insurance and reinsurance broker. Before joining Aon, he was a partner at Jones Day, where his practice focused on the defense of class action and mass tort litigation, including pharmaceutical and medical device cases. Mr. Herrmann wrote The Curmudgeon's Guide To Practicing Law (2006), co-authored Statewide Coordinated Proceedings: State Court Analogues to the Federal MDL Process (2004), taught Complex Litigation on the adjunct faculty of Case Western Reserve University School of Law, and co-founded and, for several years, co-authored the Drug & Device Law Blog. He clerked for Judge Dorothy W. Nelson of the United States Court of Appeals for the Ninth Circuit and graduated from The University of Michigan Law School (J.D. 1983) and Princeton University (A.B. 1979).

David B. Alden is a partner in Jones Day's Cleveland office, where his practice focuses on products liability litigation, including pharmaceutical and medical device cases; securities and accounting fraud litigation; and issues relating to the attorney-client privilege and work product protection. Mr. Alden graduated from The University of Michigan Law School (J.D. 1983) and Oberlin College (B.A. 1980).

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us